Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Clinical Trial
Optimal Treatment for Recurrent Clostridium Difficile
Status: Enrolling, Phase IV
Updated: 12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Trial
Optimal Treatment for Recurrent Clostridium Difficile
Status: Enrolling, Phase IV
Updated: 12/31/1969
Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR
mi
from
Little Rock, AR
Click here to add this to my saved trials
Clinical Trial
Optimal Treatment for Recurrent Clostridium Difficile
Status: Enrolling, Phase IV
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Clinical Trial
Optimal Treatment for Recurrent Clostridium Difficile
Status: Enrolling, Phase IV
Updated: 12/31/1969
VA Salt Lake City Health Care System, Salt Lake City, UT
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Solid Tumors Clinical Trial
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Florida Cancer Specialist
mi
from
Sarasota, FL
Click here to add this to my saved trials
Essential Tremor Clinical Trial
An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor
Status: Enrolling, Phase II
Updated: 3/17/2016
VA Greater Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Engaging Newly Diagnosed Men About Cancer Treatment Options
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Recurrent Plasma Cell Myeloma Clinical Trial
Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I
Updated: 2/3/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Musculoskeletal, Oncology Clinical Trial
Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)
Status: Enrolling, Phase IV
Updated: 1/28/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Orthopedics / Podiatry Clinical Trial
EMPower: Electronic Media Powering Positive Health Changes in Youth
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Illness Management and Parental Adjustment to Cancer Treatment
Status: Enrolling
Updated: 12/29/2017
Dayton Children's Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Illness Management and Parental Adjustment to Cancer Treatment
Status: Enrolling
Updated: 12/29/2017
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Diabetes Clinical Trial
Continuous Glucose Monitoring During and After Surgery
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Status: Enrolling
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Status: Enrolling
Updated: 12/31/1969
Christiana Care Health Services, Inc
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects
Status: Enrolling, Phase I
Updated: 2/18/2016
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Hematology, Pulmonary / Respiratory Diseases Clinical Trial
AZD9668, an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling, Phase I, II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Matched Targeted Therapy For High-Risk Leukemias and MDS
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Matched Targeted Therapy For High-Risk Leukemias and MDS
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Phoenix Cardiovascular Research Group, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Barrett Esophagus Clinical Trial
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Barrett Esophagus Clinical Trial
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
Las Vegas Clinic
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 2/16/2018
Childrens National Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Trial of Tolcapone With Oxaliplatin for Neuroblastoma
Status: Enrolling, Phase I
Updated: 4/17/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Trial of Tolcapone With Oxaliplatin for Neuroblastoma
Status: Enrolling, Phase I
Updated: 4/17/2018
Connecticut Children's Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Dental / Maxillofacial Surgery, Orthopedics / Podiatry Clinical Trial
Multimodal Assessment of Sensory Processing and Brain Features in Patients With Chronic Orofacial Pain
Status: Enrolling
Updated: 2/22/2018
University of Minnesota School of Dentistry
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
Status: Enrolling, Phase I
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
Status: Enrolling, Phase I
Updated: 12/31/1969
Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
Status: Enrolling, Phase I
Updated: 12/31/1969
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwell Health/Monter Cancer Center
mi
from
Lake Success, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Mantle Cell Lymphoma Clinical Trial
Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission
Status: Enrolling, Phase I, II
Updated: 3/21/2018
Emory Saint Joseph's Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Autism Clinical Trial
Parent Language Intervention for Autism
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Evanston, IL
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Ochsner Clinic Foundation-Baton Rouge
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
California Institute of Renal Research
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Cincinnati Physicians Company, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Eastern Nephrology Associates
mi
from
Greenville, NC
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Louisville Research Foundation, Inc.
mi
from
Louisville, KY
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Icahn School of Medicine at Mt Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematology Clinical Trial
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
RLS Clinical Trial
An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Josephson Wallack Munshower Neurology P.C
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Patchogue, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Stamford, CT
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Status: Enrolling, Phase
Updated: 12/31/1969
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Status: Enrolling, Phase
Updated: 12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology Clinical Trial
Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
AnMedical Health Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Langlade Hospital and Cancer Center
mi
from
Antigo, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Billings Clinic Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mount Carmel Health Center West
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Northeast Radiation Oncology Center
mi
from
Dunmore, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Adams Cancer Center
mi
from
Gettysburg, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Faris
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Mary Mercy Hospital
mi
from
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Aurora Saint Lukes Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mercy Health Mercy Campus
mi
from
Muskegon, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute - Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Lenox Hill Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Vince Lombardi Cancer Clinic - Oshkosh
mi
from
Oshkosh, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Kansas Cancer Center - Overland Park
mi
from
Overland Park, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Aria Health-Torresdale Campus
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Kaiser Permanente-Rancho Cordova Cancer Center
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Penn State Health Saint Joseph Medical Center
mi
from
Reading, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Rock Hill Radiation Therapy Center
mi
from
Rock Hill, SC
Click here to add this to my saved trials